Foman biopharma. is located in Wuhu city, Anhui province, China. We are a
company specializing in the fine production of Choline Alfoscerate
(L-alpha-Glyceryl phosphorylcholine) (GPC, cas no.: 28319-77-9) with strong
technical force, advanced technology and production equipment, improved product
quality assurance system and scientific management methods as well as
professional technician, that determined the superior quality of products. The
project covers an area of 23 hectares , building area of 230000 square meters.
The main workshops including 2 fermentation workshops, 1 synthesis workshop, 1
workshop and 1 GMP extraction workshop.Total investment is more than 4 million
US Dollar (RMB25,000,000.00).
Choline Alfoscerate
(L-alpha-Glycerylphosphorylcholine) (GPC cas no.: 28319-77-9) used in
cosmetics, dietary supplyments and food, Our company mainly manufactures and
sales Choline Alfoscerate and its series products, we always enjoyed a good
reputation for the good quality, stable supply and broad prospects for
application of the products.The company established a stable and sound sales
networks over years in Beijing, Tianjin, Shanghai, Wuhan, Guangzhou and other
provinces and cities. With the development of domestic market, the company also
expands overseas market such as Europe, North America, and Southeast Asia and
Korea etc. Also we are the largest producer in China for GPC ( cas no.:
28319-77-9) .
We will continue the
policy of innovation and pragmatic. Insist in the management idea of “customer
uppercome, reputation first”, and Company philosophy of” Quality is the root,
credibility is the basis ".
The best quality products and service will be
returned to our customers and society.
Your choice is our pride. Please witness our
passion and hard work, let us work hard together.
Innovation is the engine of an enterprise. Foman biopharma owns high-tech
R&D Center, which equipped with first-rank professional team and advanced
sophisticated instruments,Foman biopharma has also formed long-term partnership
with renowned universities and research institutions. The strong innovation
power has set up Foman biopharma's leading position in the GPC industry.
Our mission:
Design and innovation of drug
Phosphorothioation
physiological modification of DNA framework
The pathogenic mechanism and
therapy of human neurodegenerative diseases
